Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,855.00
+105.00 (2.80%)
At close: Dec 5, 2025
11.10%
Market Cap 59.09B
Revenue (ttm) 205.21B
Net Income (ttm) -1.37B
Shares Out 15.33M
EPS (ttm) -90.93
PE Ratio n/a
Forward PE n/a
Dividend 75.00 (1.95%)
Ex-Dividend Date Dec 29, 2025
Volume 62,132
Average Volume 38,277
Open 3,750.00
Previous Close 3,750.00
Day's Range 3,750.00 - 3,920.00
52-Week Range 3,070.00 - 6,130.00
Beta 0.54
RSI 54.31
Earnings Date n/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.